Cite
HARVARD Citation
Sborov, D. et al. (2022). Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. British journal of haematology. pp. 355-365. [Online].